WallStreetZenWallStreetZen

NASDAQ: TRVI
Trevi Therapeutics Inc Stock Ownership - Who owns Trevi Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Trevi Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael Thomas HeffernanDirector2026-09-15100$15.88
$1.59kSell
Michael Thomas HeffernanDirector2026-09-1518,421$3.04
$56.00kBuy
Michael Thomas HeffernanDirector2026-09-1518,321$15.09
$276.46kSell
Michael Thomas HeffernanDirector2026-09-15100$15.88
$1.59kSell
Michael Thomas HeffernanDirector2026-09-1521,052$3.33
$70.10kBuy
Michael Thomas HeffernanDirector2026-09-1520,952$15.09
$316.17kSell
Christopher GallettaController and Principal Accounting Officer2025-12-024,225$0.51
$2.16kBuy

1 of 1

TRVI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TRVI insiders and whales buy or sell their stock.

TRVI Shareholders

What type of owners hold Trevi Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Forest Baskett15.93%22,694,708$327.03MInsider
Peter W. Sonsini12.15%17,308,374$249.41MInsider
Ali Behbahani9.95%14,171,176$204.21MInsider
Anthony A. Florence Jr.9.95%14,171,176$204.21MInsider
Mohamad Makhzoumi9.95%14,171,176$204.21MInsider
Carmen Chang9.95%14,171,176$204.21MInsider
Scott D. Sandell9.95%14,171,176$204.21MInsider
Paul Edward Walker9.95%14,171,176$204.21MInsider
New Enterprise Associates 16 LP8.61%12,273,280$176.86MInsider
Joshua Makower7.28%10,376,560$149.53MInsider

1 of 3

TRVI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TRVI0.09%99.91%Net BuyingNet Buying
VCEL0.11%10.19%Net SellingNet Buying
NKTR0.11%69.83%Net SellingNet Selling
PVLA0.10%42.89%Net SellingNet Selling
BHVN0.09%19.98%Net Buying
View Top Biotech Stocks

Trevi Therapeutics Stock Ownership FAQ

Who owns Trevi Therapeutics?

Trevi Therapeutics (NASDAQ: TRVI) is owned by 0.10% institutional shareholders, 120.97% Trevi Therapeutics insiders, and 0.00% retail investors. Forest Baskett is the largest individual Trevi Therapeutics shareholder, owning 22.69M shares representing 15.93% of the company. Forest Baskett's Trevi Therapeutics shares are currently valued at $326.80M.

If you're new to stock investing, here's how to buy Trevi Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.